Rx/Reimbursement Adult Incontinence in the Netherlands
Description
In 2025, total value sales for rx/reimbursment adult incontinence in the Netherlands increased by 1% in current terms to EUR149 million. In contrast, the category continued a pattern of volume decline, with volume sales falling from 410 million units in 2024 to 403 million units in 2025, representing a decrease of 2%. This downward trend has been present for several years, driven by both demographic and behavioural factors.
Euromonitor International's Rx/Reimbursement adult incontinence in Netherlands report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2021-2025, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2030 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International's Rx/Reimbursement adult incontinence in Netherlands report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2021-2025, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2030 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
31 Pages
- Rx/Reimbursement Adult Incontinence in the Netherlands
- Euromonitor International
- April 2026
- List Of Contents And Tables
- RX/REIMBURSEMENT ADULT INCONTINENCE IN THE NETHERLANDS
- Key Data Insights
- 2025 Developments
- Insurer Contracts Steer Patient Choices, Favouring Established Brands
- Key Industry Trends
- CHART 1 Key Industry Trends for Rx/Reimbursement Adult Incontinence
- Industry Performance
- CHART 2 TENA is a Frequent Choice Due to Their Market Leadership Status
- Abena Responds to Sustainability and Efficiency Demands
- CHART 3 ABENA Responds to Sustainability Demands Through Product Efficiency
- CHART 4 Value Sales 2020-2030
- CHART 5 Volume Sales 2020-2030
- What's Next?
- Insurers Tighten Contracts as Demand Remains Resilient
- Healthcare Providers Drive Sustainability and Waste Reduction Initiatives
- CHART 6 Analyst Insight for Rx/Reimbursement Adult Incontinence
- CHART 7 Forecast Value Sales 2020-2030
- Economic Context
- CHART 8 Economic Context for Rx/Reimbursement Adult Incontinence
- CHART 9 Real Gdp Growth 2020-2030
- CHART 10 Inflation 2020-2030
- Consumer Context
- CHART 11 Consumer Context for Rx/Reimbursement Adult Incontinence
- CHART 12 Population 2020-2030
- CHART 13 Consumer Expenditure 2020-2030
- CHART 14 Population by Generation 2025
- Country Reports Disclaimer
- CHART 15 Key Industry Trends for Tissue and Hygiene
- CHART 16 Care is Positioned as Affordable Luxury
- CHART 17 Seni's Active Offers Pants Suitable for an Active Lifestyle
- CHART 18 Value Sales 2020-2030
- CHART 19 Value Sales by Category 2025
- CHART 20 Analyst Insight for Tissue and Hygiene
- CHART 21 Forecast Value Sales 2020-2030
- CHART 22 Forecast Value Sales by Category 2025-2030
- CHART 23 Company Shares 2025
- CHART 24 Brand Shares 2025
- CHART 25 Retail Channels 2020-2025
- CHART 26 Economic Context for Tissue and Hygiene
- CHART 27 Real Gdp Growth 2020-2030
- CHART 28 Inflation 2020-2030
- CHART 29 Consumer Context for Tissue and Hygiene
- CHART 30 Population 2020-2030
- CHART 31 Consumer Expenditure 2020-2030
- CHART 32 Population by Generation 2025
- TISSUE AND HYGIENE IN THE NETHERLANDS
- Executive Summary
- Albert Heijn Shifts Value Focus with Affordable Luxury Private Label
- Key Data Insights
- Key Industry Trends
- Industry Performance
- Edet’S Coreless Launch Raises Sustainability Standards and Brand Value
- Seni Active Normalises Incontinence with Discreet, Lifestyle-Led Solutions
- What's Next?
- Retailers and Brands Shift to Premium and Sustainable Formats to Drive Value
- Adult Incontinence Brands Set to Accelerate Innovation as Population Ages and Stigma Falls
- Sustainability Requirements to Reshape Portfolios and Supply Chains
- Competitive Landscape
- Albert Heijn and Branded Leaders Shape Value with Premiumisation
- Channels
- Albert Heijn and Jumbo Retain Shopper Loyalty through Weekly Convenience
- Economic Context
- Consumer Context
- Country Reports Disclaimer
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
